rs473041
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_014384.3(ACAD8):c.210+70T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.318 in 1,331,044 control chromosomes in the GnomAD database, including 70,336 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.27 ( 6183 hom., cov: 32)
Exomes 𝑓: 0.32 ( 64153 hom. )
Consequence
ACAD8
NM_014384.3 intron
NM_014384.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.158
Publications
10 publications found
Genes affected
ACAD8 (HGNC:87): (acyl-CoA dehydrogenase family member 8) This gene encodes a member of the acyl-CoA dehydrogenase family of enzymes that catalyze the dehydrogenation of acyl-CoA derivatives in the metabolism of fatty acids or branch chained amino acids. The encoded protein is a mitochondrial enzyme that functions in catabolism of the branched-chain amino acid valine. Defects in this gene are the cause of isobutyryl-CoA dehydrogenase deficiency.[provided by RefSeq, Nov 2009]
ACAD8 Gene-Disease associations (from GenCC):
- isobutyryl-CoA dehydrogenase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, ClinGen, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 11-134256718-T-C is Benign according to our data. Variant chr11-134256718-T-C is described in ClinVar as Benign. ClinVar VariationId is 1223942.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.364 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.271 AC: 41204AN: 152038Hom.: 6181 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
41204
AN:
152038
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.324 AC: 381413AN: 1178888Hom.: 64153 Cov.: 15 AF XY: 0.325 AC XY: 193343AN XY: 595328 show subpopulations
GnomAD4 exome
AF:
AC:
381413
AN:
1178888
Hom.:
Cov.:
15
AF XY:
AC XY:
193343
AN XY:
595328
show subpopulations
African (AFR)
AF:
AC:
3353
AN:
27360
American (AMR)
AF:
AC:
15987
AN:
37984
Ashkenazi Jewish (ASJ)
AF:
AC:
9941
AN:
22192
East Asian (EAS)
AF:
AC:
9046
AN:
38156
South Asian (SAS)
AF:
AC:
23732
AN:
73910
European-Finnish (FIN)
AF:
AC:
10945
AN:
50632
Middle Eastern (MID)
AF:
AC:
2073
AN:
5094
European-Non Finnish (NFE)
AF:
AC:
289886
AN:
872956
Other (OTH)
AF:
AC:
16450
AN:
50604
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
12739
25478
38217
50956
63695
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
8554
17108
25662
34216
42770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.271 AC: 41221AN: 152156Hom.: 6183 Cov.: 32 AF XY: 0.270 AC XY: 20055AN XY: 74372 show subpopulations
GnomAD4 genome
AF:
AC:
41221
AN:
152156
Hom.:
Cov.:
32
AF XY:
AC XY:
20055
AN XY:
74372
show subpopulations
African (AFR)
AF:
AC:
5433
AN:
41516
American (AMR)
AF:
AC:
5694
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
1538
AN:
3470
East Asian (EAS)
AF:
AC:
1190
AN:
5156
South Asian (SAS)
AF:
AC:
1557
AN:
4818
European-Finnish (FIN)
AF:
AC:
2325
AN:
10608
Middle Eastern (MID)
AF:
AC:
116
AN:
294
European-Non Finnish (NFE)
AF:
AC:
22529
AN:
67992
Other (OTH)
AF:
AC:
657
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1500
3000
4500
6000
7500
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
440
880
1320
1760
2200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
909
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.